The University of Chicago Comprehensive Cancer Center (UCCCC) is a formal academic unit within the Division of the Biological Sciences (BSD), and the main body within the University to plan, facilitate, and promote research, education, community outreach, and health information services all focused on cancer. The Director has Department Chair status, and serves as a standing member of the BSD Research Advisory Committee and the Clinical Cancer Strategic Growth Committee, the major policy-making bodies of the BSD regarding research and cancer clinical programs. The Associate Director for Administration has the status of Departmental Executive Administration (EA) and attends all BSD-level and Medical Center (UCMC) Operations meetings (meetings of the EAs and senior BSD administrators), thereby representing the UCCCC interests at the institutional level. The Director has control of the budgets of the CCSG, the ACS Institutional Research Grant, and all large, multi-investigator grants administered by the UCCCC, e.g., POI grants. Breast Cancer SPORE as well as all UCCCC endowment income, gift income, discretionary funds, and operational budget provided by the BSD. The Director has authority over UCCCC membership and appointments, direct and shared authority over shared resources, and direct authority over 5,000 sq ft of office space, 5,000 sq ft of dry lab space and 23,000 sq ft of wet lab space. Under the leadership of Dr. Marcy List, Associate Director for Administration, the UCCCC Administrative Unit is responsible for oversight and management of those activities that support the mission of the Center and the research of its members. The Administrative Unit includes: Finances and Human Resources (Director + 3 FTEs) responsible for management of $7.5M in federal and non-federal grants and contracts and $10M in Philanthropy, and HR issues for 50 UCCCC employees;Informatics (Director + 5 FTEs) responsible for all informatics and database support for UCCCC administrative groups, the CCTO and UCCCC investigators as well as coordinating UCCCC IT activities with those of the BSD and UCMC, and supporting the UCCCC Website;grant support staff (2 FTEs) responsible for all non-financial pre- and post-award for multi-investigators grants (noted above), program development support (planning and evaluation activities, coordination of activities related to membership and recruitment, seminars and meeting coordination).
The Administrative Unit of the UCCCC provides the support and infrastructure to researchers and clinicians to collaborate in fulfilling the mission of the UCCCC. UCCCC Administration plays a key role in facilitating inter and intraprogrammafic interactions, managing pilot funding opportunities, new core development, and the recruitment of new faculty. The Administration also plays a critical role in clinical research operations by providing the basic informatics infrastructure and working with investigators to assess evolving needs.
|Feng, Christine H; Gerry, Emily; Chmura, Steven J et al. (2015) An image-guided study of setup reproducibility of postmastectomy breast cancer patients treated with inverse-planned intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 91:58-64|
|Ming, Mei; Zhao, Baozhong; Shea, Christopher R et al. (2015) Loss of sirtuin 1 (SIRT1) disrupts skin barrier integrity and sensitizes mice to epicutaneous allergen challenge. J Allergy Clin Immunol 135:936-45.e4|
|Ming, Mei; Zhao, Baozhong; Qiang, Lei et al. (2015) Effect of immunosuppressants tacrolimus and mycophenolate mofetil on the keratinocyte UVB response. Photochem Photobiol 91:242-7|
|Shah, Palak; He, Yu-Ying (2015) Molecular regulation of UV-induced DNA repair. Photochem Photobiol 91:254-64|
|Ming, Mei; Han, Weinong; Zhao, Baozhong et al. (2014) SIRT6 promotes COX-2 expression and acts as an oncogene in skin cancer. Cancer Res 74:5925-33|
|Ramírez, Jacqueline; Kim, Tae Won; Liu, Wanqing et al. (2014) A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469. Pharmacogenet Genomics 24:129-32|
|Rudra, Sonali; Al-Hallaq, Hania A; Feng, Christine et al. (2014) Effect of RTOG breast/chest wall guidelines on dose-volume histogram parameters. J Appl Clin Med Phys 15:4547|
|Weng, Liming; Ziliak, Dana; Lacroix, Bonnie et al. (2014) Integrative "omic" analysis for tamoxifen sensitivity through cell based models. PLoS One 9:e93420|
|Stumpf, Melanie; Zhou, Xuyu; Chikuma, Shunsuke et al. (2014) Tyrosine 201 of the cytoplasmic tail of CTLA-4 critically affects T regulatory cell suppressive function. Eur J Immunol 44:1737-46|
|Geeleher, Paul; Cox, Nancy J; Huang, R Stephanie (2014) Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines. Genome Biol 15:R47|
Showing the most recent 10 out of 354 publications